Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody

被引:9
作者
Liu, Gao-Qin [1 ,2 ]
Lu, Pei-Rong [1 ,2 ]
Li, Long-Biao [1 ]
Zhang, Xue-Guang [2 ]
机构
[1] Soochow Univ, Dept Ophthalmol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China
[2] Soochow Univ, Jiangsu Inst Clin Immunol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China
关键词
corneal neovascularization; alkali injury; chemokine; ENDOTHELIAL GROWTH-FACTOR; CELL-DERIVED FACTOR; CXCR4; CHEMOATTRACTANT; ANGIOGENESIS; FACTOR-1;
D O I
10.3980/j.issn.2222-3959.2012.01.02
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To explore the effect of SDF-1 alpha on the development of experimental corneal neovascularization (CRNV). METHODS: CRNV was induced by alkali injury in mice. The expression of SDF-1 alpha and CXCR4 in burned corneas was examined by Flow Cytometry. Neutralizing anti-mouse SDF-1 alpha antibody was locally administrated after alkali injury and the formation of CRNV 2 weeks after injury was assessed by Immunohistochemistry. The expression of VEGF and C-Kit in burned corneas was detected by RT-PCR. RESULTS: The number of CRNV peaks at 2 weeks after alkali injury. Compared to control group, SDF-1 alpha neutralizing antibody treatment significantly decreased the number of CRNV. RT-PCR confirmed that SDF-1 alpha neutralizing antibody treatment resulted in decreased intracorneal VEGF and C-Kit expression. CONCLUSION: SDF-1 alpha neutralizing antibody treated mice exhibited impaired experimental CRNV through down regulated VEGF and C-Kit expression.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 21 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   Corneal avascularity is due to soluble VEGF receptor-1 [J].
Ambati, Balamurali K. ;
Nozaki, Miho ;
Singh, Nirbhai ;
Takeda, Atsunobu ;
Jani, Pooja D. ;
Suthar, Tushar ;
Albuquerque, Romulo J. C. ;
Richter, Elizabeth ;
Sakurai, Eiji ;
Newcomb, Michael T. ;
Kleinman, Mark E. ;
Caldwell, Ruth B. ;
Lin, Qing ;
Ogura, Yuichiro ;
Orecchia, Angela ;
Samuelson, Don A. ;
Agnew, Dalen W. ;
St. Leger, Judy ;
Green, W. Richard ;
Mahasreshti, Parameshwar J. ;
Curiel, David T. ;
Kwan, Donna ;
Marsh, Helene ;
Ikeda, Sakae ;
Leiper, Lucy J. ;
Collinson, J. Martin ;
Bogdanovich, Sasha ;
Khurana, Tejvir S. ;
Shibuya, Masabumi ;
Baldwin, Megan E. ;
Ferrara, Napoleone ;
Gerber, Hans-Peter ;
De Falco, Sandro ;
Witta, Jassir ;
Baffi, Judit Z. ;
Raisler, Brian J. ;
Ambati, Jayakrishna .
NATURE, 2006, 443 (7114) :993-997
[3]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[4]   The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells [J].
Kijowski, J ;
Baj-Krzyworzeka, M ;
Majka, M ;
Reca, R ;
Marquez, LA ;
Christofidou-Solomidou, M ;
Janowska-Wieczorek, A ;
Ratajczak, MZ .
STEM CELLS, 2001, 19 (05) :453-466
[5]  
Kucia M, 2004, J MOL HISTOL, V35, P233
[6]   CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway [J].
Liang, Zhongxing ;
Brooks, Joann ;
Willard, Margaret ;
Liang, Ke ;
Yoon, Younghyoun ;
Kang, Seunghee ;
Shim, Hyunsuk .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 359 (03) :716-722
[7]  
Liu GQ, 2011, MOL VIS, V17, P2129
[8]   Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal Neovascularization through enhanced antiangiogenic factor expression [J].
Lu, Peirong ;
Li, Longbiao ;
Kuno, Kouji ;
Wu, Yu ;
Baba, Tomohisa ;
Li, Ying-yi ;
Zhang, Xueguang ;
Mukaida, Naofumi .
JOURNAL OF IMMUNOLOGY, 2008, 180 (06) :4283-4291
[9]  
Lu PR, 2007, CORNEA, V26, P199, DOI 10.1097/01.ico.0000248385.16896.34
[10]   CXC chemokine receptor expression on human endothelial cells [J].
Murdoch, C ;
Monk, PN ;
Finn, A .
CYTOKINE, 1999, 11 (09) :704-712